ID

27354

Descrição

Treatment of Bronchial Asthma With Borage and Echium Seed Oils; ODM derived from: https://clinicaltrials.gov/show/NCT00806442

Link

https://clinicaltrials.gov/show/NCT00806442

Palavras-chave

Versões (1)
  1. 09/11/2017 09/11/2017 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

9 de novembro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Bronchial Asthma NCT00806442

Inglês

Eligibility Bronchial Asthma NCT00806442

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of bronchial asthma
Descrição

Asthma

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0004096
male or female 18 years to 65 years of age
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
fev1 50 to 90% of predicted, or personal best.
Descrição

FEV1

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0849974
improvement in fev1 > 12% after administration of a beta-2 agonist.
Descrição

Adrenergic beta-2 Receptor Agonists | FEV1 Improvement Percentage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2936789
UMLS CUI [2,1]
C0849974
UMLS CUI [2,2]
C2986411
UMLS CUI [2,3]
C0439165
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
smoking history of > 10 pack years or active smoking within the past year.
Descrição

smoking cigarettes: ____ pack-years history | Tobacco use

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2230126
UMLS CUI [2]
C0543414
due to possible effects on leukotriene biosynthesis, use of the following asthma treatments within the preceding month will be exclusion criteria:
Descrição

Effect Leukotriene biosynthetic process | Therapeutic procedure Asthma | Exclusion Criteria

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1280500
UMLS CUI [1,2]
C1157321
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0004096
UMLS CUI [3]
C0680251
leukotriene modifying drugs,
Descrição

Pharmaceutical Preparations Leukotrienes Changing

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0023545
UMLS CUI [1,3]
C0392747
theophylline
Descrição

Theophylline

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0039771
oral steroids.
Descrição

Steroids Oral

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C1527415
dietary supplements with fatty acids or other products that may interfere with leukotriene generation.
Descrição

Dietary Supplements Fatty Acids | Pharmaceutical Preparations Interfere with Leukotriene biosynthetic process

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0242295
UMLS CUI [1,2]
C0015684
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C1157321
treatment within the previous three months with omalizumab (monoclonal antibody directed against ige)
Descrição

omalizumab

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0966225
subjects will not be permitted to take non-steroidal anti-inflammatory drugs in the week prior to any measurements of ex vivo leukotriene generation because of their effects on leukotriene biosynthesis via inhibition of prostaglandin generation.
Descrição

Anti-Inflammatory Agents, Non-Steroidal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003211
a history of aspirin-sensitive asthma
Descrição

Asthma aspirin-sensitive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0856716
significant abnormalities in cbc, differential white cell count, renal function, and liver function, or urinalysis.
Descrição

CBC abnormal | Differential white blood cell count abnormal | Abnormal renal function | Liver Dysfunction | Urine screening abnormal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0742009
UMLS CUI [2]
C0860796
UMLS CUI [3]
C0151746
UMLS CUI [4]
C0086565
UMLS CUI [5]
C0438142
any serious co-morbid medical condition.
Descrição

Comorbidity Serious

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
Voltar ao início da página

Similar models

Eligibility Bronchial Asthma NCT00806442

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Asthma
Item
diagnosis of bronchial asthma
boolean
C0004096 (UMLS CUI [1])
Age
Item
male or female 18 years to 65 years of age
boolean
C0001779 (UMLS CUI [1])
FEV1
Item
fev1 50 to 90% of predicted, or personal best.
boolean
C0849974 (UMLS CUI [1])
Adrenergic beta-2 Receptor Agonists | FEV1 Improvement Percentage
Item
improvement in fev1 > 12% after administration of a beta-2 agonist.
boolean
C2936789 (UMLS CUI [1])
C0849974 (UMLS CUI [2,1])
C2986411 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
smoking cigarettes: ____ pack-years history | Tobacco use
Item
smoking history of > 10 pack years or active smoking within the past year.
boolean
C2230126 (UMLS CUI [1])
C0543414 (UMLS CUI [2])
Effect Leukotriene biosynthetic process | Therapeutic procedure Asthma | Exclusion Criteria
Item
due to possible effects on leukotriene biosynthesis, use of the following asthma treatments within the preceding month will be exclusion criteria:
boolean
C1280500 (UMLS CUI [1,1])
C1157321 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0004096 (UMLS CUI [2,2])
C0680251 (UMLS CUI [3])
Pharmaceutical Preparations Leukotrienes Changing
Item
leukotriene modifying drugs,
boolean
C0013227 (UMLS CUI [1,1])
C0023545 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
Theophylline
Item
theophylline
boolean
C0039771 (UMLS CUI [1])
Steroids Oral
Item
oral steroids.
boolean
C0038317 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Dietary Supplements Fatty Acids | Pharmaceutical Preparations Interfere with Leukotriene biosynthetic process
Item
dietary supplements with fatty acids or other products that may interfere with leukotriene generation.
boolean
C0242295 (UMLS CUI [1,1])
C0015684 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C1157321 (UMLS CUI [2,3])
omalizumab
Item
treatment within the previous three months with omalizumab (monoclonal antibody directed against ige)
boolean
C0966225 (UMLS CUI [1])
Anti-Inflammatory Agents, Non-Steroidal
Item
subjects will not be permitted to take non-steroidal anti-inflammatory drugs in the week prior to any measurements of ex vivo leukotriene generation because of their effects on leukotriene biosynthesis via inhibition of prostaglandin generation.
boolean
C0003211 (UMLS CUI [1])
Asthma aspirin-sensitive
Item
a history of aspirin-sensitive asthma
boolean
C0856716 (UMLS CUI [1])
CBC abnormal | Differential white blood cell count abnormal | Abnormal renal function | Liver Dysfunction | Urine screening abnormal
Item
significant abnormalities in cbc, differential white cell count, renal function, and liver function, or urinalysis.
boolean
C0742009 (UMLS CUI [1])
C0860796 (UMLS CUI [2])
C0151746 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C0438142 (UMLS CUI [5])
Comorbidity Serious
Item
any serious co-morbid medical condition.
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial